Together with you we challenge today’s possibilities and enable the unthinkable

Netherlands Center for the Clinical Advancement of Stem Cell & Gene Therapies

FIND OUT MORE

Your therapy is unique and important to patients. At NECSTGEN we enable the next generation of therapies by offering development support and GMP production of cell and gene therapies.

Welcome to NECSTGEN

The rapid developments in cell and gene therapy research and the industry as a whole provide remedies to increasingly more patients while offering the potential to decrease the burden on society. NECSTGEN will support clinicians, academic groups and small industrial therapy developers globally to bring cell and gene therapies to patients.

More about us

News & Events

€56 million from NL Groeifonds to NecstGen and RegMedXB

09 April 2021

Today, the Dutch cabinet announced the investment of €56 million into the establishment of a “pilot factory” for regenerative therapies. NecstGen and three other facilities will form a chain covering the development and…

Markwin Velders joins strategic advisory board

28 January 2021

Markwin Velders brings 20 years of experience in cell and gene therapy. He is Chairman of HollandBIO and co-founder of various biotech companies. As VP Operation at Kite Pharma, he led the establishment of a large scale CAR-T manufacturing site…

Sander van Deventer joins strategic advisory board

19 JANUARY 2021

Sander van Deventer is professor of Translational gastroenterology at the LUMC and partner at Forbion. Among others, he co-founded gene therapy developer uniQure and played a crucial role in the commercialization of the first gene therapy Glybera.